Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

Tetralogy of Fallot Clinical Trial

Official title:

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02967315
• Other study ID #: 2018-0399
• Secondary ID: 2013-0276SMPH/SU
• Status: Completed
• Phase: N/A
• Start date: June 6, 2014
• Est. completion date: March 18, 2021

Study information

• Verified date: April 2021
• Source: University of Wisconsin, Madison
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the correlation between fluid volume status and right ventricular volume and function, in those with free pulmonary valve insufficiency after Tetralogy of Fallot (TOF) repair.

Description:

The purpose of this study is to measure the changes in Right Ventricular size and function with changes in preload, using cardiovascular magnetic resonance (CMR). Based on an intensive research and clinical observations the investigators hypothesize that changes in volume status cause a statistically significant difference in the Cardiovascular magnetic resonance (CMR) measured RV End Diastolic Volume (EDV), end-systolic volume (ESV), ejection fraction (EF) and pulmonary regurgitation (PR). The investigator hypothesizes that smaller changes will occur in left ventricular LV EDV, ESV, and EF. 1. To establish a correlation between the changes in preload volume status and RV size and function in patients with free pulmonary insufficiency (PI) after TOF repair using CMRI. 2. To assess the effects of preload status on the measured severity of pulmonary regurgitation (PR). 3. To assess the effects of preload status on the left ventricular (LV) size This study will be conducted in compliance with this protocol, good clinical practice and the applicable regulatory requirements.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4
• Est. completion date: March 18, 2021
• Est. primary completion date: March 18, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. TOF patients who have had repair using a transannular patch.

2. Patients that present with free pulmonary insufficiency.

3. Are older than 18 years.

Exclusion Criteria:

1. Patients who have lesions predisposing to chronic volume overload (i.e. patients with significant residual postoperative ventricular septal defects (VSD), or large aorto-pulmonary collaterals or more than moderate tricuspid insufficiency) since all these hemodynamic conditions can influence the late function of the right ventricle and potentially affect the response of the right side of the heart in changes in volume status

2. Patients who had a valve sparing TOF repair and have less than free pulmonary insufficiency.

3. Patients who have significant residual right-sided obstruction (i.e. patients who have residual RVOT obstruction or significant residual branch pulmonary artery stenosis), as it is shown that residual pulmonary stenosis may protect from RV dilation and from deterioration of the RV function.

4. Patients who cannot be reconstructed with a transannular patch and/or require a right

ventricle to pulmonary artery homograft for reconstruction including:

• pulmonary atresia and VSD
• patients with anomalous coronary crossing the right ventricular outflow tract (RVOT) and
• patients with TOF-absent pulmonary valve syndrome.

5. Patients with renal failure and renal insufficiency

6. Patients with uncompensated heart failure

7. Cancer patients

8. Latex allergic patients

9. Patients with diabetes

10. Pregnant females

11. Prisoners

12. Individuals who lack consent capacity

Related Conditions & MeSH terms

• Tetralogy of Fallot

Intervention

Procedure:
• Cardiac Magnetic Resonance Imaging (CMRI)
There will be 2 CMRIs. The first one will be patient's routine clinically schedule CMRI after the patient has fasted for 12 hours.This CMRI uses contrast. The second CMRI will be the research CMRI after the fluid administration. This CMRI does not use contrast.
• Central venous line placement
An ultrasound guided central line catheter will be placed in the internal jugular vein (IJV) under local anesthesia.
• Chest X-ray
A chest X-ray will be performed for safety reasons to rule out pneumothorax (< 1% risk) after central line placement.
• Fluid administration
Administration of 15cc/kg of normal saline for fluid hydration through peripheral IV that is placed for the MRI contrast administration.
• Blood Draw
One to two teaspoons of blood will be drawn for basic metabolic panel.
• Pregnancy test
A urine pregnancy test will be performed in female subjects.
• Electrocardiogram
12 lead ECG

Locations

Country	Name	City	State
United States	University of Wisconsin-Madison	Madison	Wisconsin

Sponsors (1)

Lead Sponsor	Collaborator
University of Wisconsin, Madison

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postload volume status	The following will be measured to define the postload volume status: Left and right ventricle end diastolic volume (milliliters [ml]); Ejection fraction (%); pulmonary regurgitation	24 months